When confronting a frightening condition like bladder cancer, patients may fall into a rabbit hole of information online. It can be challenging to discern what sites to trust and where to turn. Not only are patients facing concerns about their own survival, but also worries over sensitive issues such as bladder function and sexual health. In this situation, it can be difficult for patients to open up to providers about their fears. […]
By applying adult learning principles, we’ve discovered that it’s possible to engage providers longer and help them retain more knowledge about a therapy. […]
Researching clinical trials is a formidable challenge. Figuring out which trials offer the most promise to a particular patient is a monumental job, with life-altering implications. With hundreds of thousands of registered clinical trials across the country, it’s no wonder most people are overwhelmed at the prospect of it all. […]
A detailed survey of PlatformQ Health (PQH) digital education attendees found patients and families are realizing meaningful changes as a result of the learnings they gained during these programs. […]
The initiative succeeded in improving clinicians’ understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. […]
Together with leading advocacy organizations, we’ve created unique learning channels that help make a difference in the lives of patients with conditions such as multiple sclerosis, dementia, and many other neurological conditions. […]
Spring is here and we are excited to share some of our latest articles and webinars that explore pressing medical education and healthcare topics that you may be interested in. Through this seasonal newsletter, we aim to show the breadth and depth of our collaborations and how we work with our partners to go beyond […]
“CKD is a silent disease,” said Cheung. “There is significant under-recognition that people may have it. That’s really unfortunate because there are effective therapies, ranging from renin-angiotensin system inhibitors to statins. […]
Promoting new therapies in the rare disease space comes with unique challenges. There are many hurdles to gaining market adoption, particularly for those among the first to market in a disease state. […]
Hear from 10-year cancer survivor, influential advocate and TOUCH CEO, Ricki Fairley, as she dispels myths around clinical trials and discusses how to drive more equitable trial enrollment. […]
In our latest collaboration with CME Palooza, we hosted a webinar featuring Jeanne Regnante, Chief Health Equity and Diversity Officer of the lung cancer advocacy organization, LUNGevity, Shawn Feliciano, a patient with MS who has participated in clinical trial research and Sapana Panday, Senior Director of Digital Education at PlatformQ Health. During this conversation the […]
Leaders from the Moffitt Cancer Center, NORD and TOUCH speak on behalf of their organizations about what they are doing in their day to day to make a difference in the lives of Black or other underserved patient populations. […]
A strong pharma product launch can help bolster a drug’s performance over its lifecycle. Most new drugs continue with the revenue trajectory achieved at launch. An analysis by the Deloitte Center for Health Solution found roughly 80 percent of products that met or exceeded initial expectations continued their success rate in subsequent years. That’s why educating physicians quickly in the early months of a product launch delivers a notable advantage. […]
As our #ASH21 blog comes to a close, the hematology community has much to look forward to with a plethora of clinically relevant data, emerging novel therapies, a better understanding of mechanisms of resistance that can lead to new therapeutic strategies, and a strong commitment from the leading hematology organization to address disparities and ensure equity. […]
Day 3 of the ASH Annual Meeting & Exposition kicked off with a continuation of the Diversity, Health, and Equity track, focusing on changing the tide from paternalistic patterns and exclusion of marginalized populations to inclusion of clinical trial design and a “deliberateness” of engaging minority communities from the very start. This important effort to reevaluate the status quo is part of the hematology community’s commitment to ensuring equity and addressing disparities. […]
Read a short recap of insights about day 2 of ASH, the world’s largest professional society committed to conquering blood diseases, ASH. […]
The first day of the highly anticipated 63rd ASH Annual Meeting & Exposition kicked off with a new track focused on diversity, health, and equity. As the world’s largest professional society committed to conquering blood diseases, ASH is building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences. […]
Early education of the marketplace is crucial for a successful pharmaceutical product launch. We’re pleased to share how our peer-to-peer education model drives more efficient provider education as well as alignment with the field force. Download the PDF Version: 2021-Infographic-DS Be sure to check out our other End of Year Infographics: Continuing Medical […]
As patients take an increasingly active role in their own care, education plays a central role. Knowledge fosters shared decision making among providers, patients, and their families. We’re pleased to share outcomes from our digital patient education model. Download the PDF version: 2021-Infographic-Patient.pdf Be sure to check out our other End of Year Infographics: […]
Tracking outcomes is essential to PlatformQ Health education, both as a means to continually enhance engagement and to assess knowledge gaps that support the development of future programming. We’re pleased to share the most significant outcomes across our CME programs and their impact on clinical practice and patient outcomes. Download the PDF version now: […]
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. […]
Tethered education: Aligning patients and providers What spurs patients to choose one treatment option over another? What are the hurdles patients face when presented with a newly FDA approved drug? What barriers to change keep physicians from prescribing new treatments? The practice of shared decision making can help answer these crucial questions. This approach can […]
Clinicians are facing challenges with diagnosing a wide range of conditions. […]
Peer-to-peer engagement can deliver more than mere video views – and can break through digital fatigue.
[…]
New collaborations are bringing innovative approaches to patient outreach and education to address diversity in clinical trials. […]
A year-long initiative to produce rare disease digital education made a positive change on clinical practice and patient outcomes. […]
The patient voice is the presence of the patients’ lived experiences, values, and preferences in medical education, often in the form of video testimonials. It has the power to spur real change in healthcare by capturing the attention of HCPs and inciting them to make improvements in their practice. […]
In 2020, PlatformQ Health’s mission to improve health outcomes through trusted digital education did not waver. We are grateful to be a steady hand for our partners, HCP and patient learners, and supporters, providing continuity through seamless shifts into the digital world. Digital education is at the heart of our past and current success, and our ability to adapt and innovate is a critical component of our future-focused orientation. […]
Our world will be different in 2021 and beyond. The question is, how will we, as a health education community, evolve? Here we are, finally, in 2021. For months we looked forward to turning a new year and imagined life where we are not jumping from crisis to crisis—put simply, life that just feels normal. […]
From patients to caregivers, associations to pharmaceutical companies, COVID-19 ignited transformative digital innovations across healthcare. Robert Rosenbloom, our CEO, reflects on 2020 and looks to the year ahead. […]
Under normal circumstances, managing a complicated health condition can be challenging enough with limited in-person time. Now with COVID-19, doctors are scrambling for new strategies to provide care to their patients, leading to a dramatic increase in the reliance on telemedicine. One solution gaining traction: Tethered education. […]
We surveyed more than 200 HCPs to learn more about how they plan on learning in our ‘new normal’ and what information they’re seeking most often now. […]
Going to see your doctor can be a frightening experience: you may be worried you have a serious affliction, or maybe you’re just going to follow up for a chronic condition, or maybe there is a procedure you are facing that you know will be painful. […]